Product How it works Pricing Blog FAQ About Contact

Spanish and European health care stocks

The official accounts of 65 Spanish and European companies in the health care sector, ranked by revenue for their latest fiscal year. Each one links to its page, with the filing behind every figure.

Of the 65 companies, 38 earned more in their latest fiscal year than in the one before; 22 closed it with a loss.

Each amount is in the currency the company reports in; the rank converts revenue to US dollars at the 16 November 2026 exchange rate.

US companies in the sector are in US health care stocks.

Spain

RankCompanyTickerRevenueNet incomeNet income change
1GrifolsBME: GRF€7,524m€402.0m+156.2%
2AlmirallBME: ALM€1,108m€46.2m+354.9%
3Laboratorios RoviBME: ROVI€743.5m€140.4m+2.6%
4Faes FarmaBME: FAE€610.5m€79.6m−28.5%
5Reig JofreBME: RJF€331.1m€5.0m−51.6%
6Clínica BavieraBME: CBAV€301.8m€42.1m+4.6%
7PrimBME: PRM€251.8m€16.7m+52.8%
8PharmaMarBME: PHM€221.4m€75.0m+187.0%
9Atrys HealthBME: ATRY€141.0m−€100.3m—

Rest of Europe

RankCompanyTickerRevenueNet incomeNet income change
1AstraZenecaLON: AZN$58,739m$10,225m+45.3%
2Novo NordiskCPH: NOVO-BDKK 309,064mDKK 102,434m+1.4%
3PhilipsAMS: PHIA€17,834m€895.0m—
4HaleonLON: HLN£11,030m£1,667m+15.6%
5emeisEPA: EMEIS€5,895m−€298.4m—
6Smith & NephewLON: SN$6,164m$625.0m+51.7%
7Ramsay Générale de SantéEPA: GDS€5,381m−€48.3m—
8ClarianeEPA: CLARI€5,310m€1.6m—
9bioMérieuxEPA: BIM€4,070m€397.5m−8.0%
10ArgenxEBR: ARGX$4,151m$1,292m+55.1%
11ColoplastCPH: COLO-BDKK 27,874mDKK 3,636m−28.0%
12GenmabCPH: GMAB$3,720m$963.0m−15.0%
13GetingeSTO: GETI-BSEK 34,969mSEK 2,258m+37.9%
14DemantCPH: DEMANTDKK 22,971mDKK 1,545m−35.3%
15Hikma PharmaceuticalsLON: HIK$3,349m$402.0m+12.0%
16Sartorius Stedim BiotechEPA: DIM€2,968m€265.6m+51.7%
17AmplifonBIT: AMP€2,396m€91.3m−37.2%
18Convatec GroupLON: CTEC$2,439m$175.0m−8.1%
19Spire Healthcare GroupLON: SPI£1,580m£16.4m−35.4%
20OrionHEL: ORNBV€1,890m€500.3m+51.7%
21Zealand PharmaCPH: ZEALDKK 9,215mDKK 6,455m—
22DiaSorinBIT: DIA€1,195m€155.6m−17.3%
23Safilo GroupBIT: SFL€983.4m€48.6m+118.2%
24LNA SantéEPA: LNA€912.7m€24.1m+10.7%
25GenusLON: GNS£658.1m£285.3m+1,378.2%
26GuerbetEPA: GBT€786.4m−€108.3m−773.5%
27Ion Beam ApplicationsEBR: IBAB€620.2m€12.7m+37.6%
28EL.En.BIT: ELN€596.9m€43.4m−15.9%
29VetoquinolEPA: VETO€525.7m€57.4m−2.3%
30Garofalo Health CareBIT: GHC€487.1m€23.4m+7.9%
31Pharming GroupAMS: PHARM$376.1m$2.9m—
32PhilogenBIT: PHIL€320.1m€229.7m+407.1%
33Oxford Nanopore TechnologiesLON: ONT£223.9m−£145.2m—
34LumibirdEPA: LBIRD€225.6m€14.0m+146.0%
35Oxford BiomedicaLON: OXB£168.7m−£30.1m—
36ValnevaEPA: VLA€174.7m−€115.2m—
37PharmanutraBIT: PHN€131.7m€20.0m+20.8%
38EuKedosBIT: EUK€52.9m−€0.7m—
39NanobiotixEPA: NANO€29.6m−€24.0m—
40MedinCellEPA: MEDCL€24.3m−€31.3m—
41ArcticZymes TechnologiesOSL: AZTNOK 112.6mNOK 9.7m+15.0%
42Hyloris PharmaceuticalsEBR: HYL€7.2m−€6.3m—
43Onward MedicalEBR: ONWD€5.4m−€41.8m—
44InventivaEPA: IVA€4.5m−€354.1m—
45ABIONYX PharmaEPA: ABNX€4.1m−€5.6m—
46OSE ImmunotherapeuticsEPA: OSE€2.6m−€37.7m−200.7%
47AdociaEPA: ADOC€1.5m−€16.6m—
48TransgeneEPA: TNG€0.1m−€37.5m—
49Aqua Bio TechnologyOSL: ABTECNOK 1.3mNOK 97.7m—
50CarvolixEPA: CVX€0.0m−€25.0m—

And 6 more: Abivax · DBV Technologies · Euroapi · GSK · Sanofi · Syncona.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell.